Cheng Xiong Lin
Directeur Général chez Hunan Huairen Great Health Industry Development Co., Ltd.
Postes actifs de Cheng Xiong Lin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hunan Huairen Great Health Industry Development Co., Ltd.
 Hunan Huairen Great Health Industry Development Co., Ltd. Drugstore ChainsRetail Trade Part of LBX Pharmacy Chain JSC, Hunan Huairen Great Health Industry Development Co., Ltd. sells Chinese medicine, Chinese medicinal materials, and antibiotic preparations. The company is based in Huaihua, China. The Chinese company was founded in 1996. The CEO is Cheng Xiong Lin. Hunan Huairen Great Health Industry Development Co. was acquired by LBX Pharmacy Chain JSC on April 20, 2022 for $257.04 million. | Directeur Général | - | - |
| Président | - | - |
Historique de carrière de Cheng Xiong Lin
Statistiques
Internationale
| Chine | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorielle
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hunan Huairen Great Health Industry Development Co., Ltd.
Hunan Huairen Great Health Industry Development Co., Ltd. Drugstore ChainsRetail Trade Part of LBX Pharmacy Chain JSC, Hunan Huairen Great Health Industry Development Co., Ltd. sells Chinese medicine, Chinese medicinal materials, and antibiotic preparations. The company is based in Huaihua, China. The Chinese company was founded in 1996. The CEO is Cheng Xiong Lin. Hunan Huairen Great Health Industry Development Co. was acquired by LBX Pharmacy Chain JSC on April 20, 2022 for $257.04 million. | Retail Trade |
- Bourse
- Insiders
- Cheng Xiong Lin
- Expérience
